← Open Payments lookup

LINDA YAUL: Open Payments

NPI 1982484242 · RIDGELAND, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$332 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $404 · 2025 $332

Food & beverage: $332
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP3$47
ABIOMED1$47
Regeneron Healthcare Solutions, Inc.2$42
Boehringer Ingelheim Pharmaceuticals, Inc.2$41
Mallinckrodt Hospital Products Inc.2$40
GENZYME CORPORATION2$38
Takeda Pharmaceuticals U.S.A., Inc.2$35
United Therapeutics Corporation1$26
Merck Sharp & Dohme LLC1$17

Products named: DUPIXENT, OFEV, ACTHAR, GLASSIA, TEZSPIRE, Tyvaso, ZERBAXA, AIRSUPRA.

Industry payments across MS — which companies pay providers there.